Athyrium Capital Management, LP (Stamford, CT)
Mr. Sean Wang is an Analyst at Athyrium Capital Management, having joined the firm in 2016. Mr. Wang is part of the Investment Team at Athyrium and looks to invest in commercial-stage healthcare companies. Previously, he was with Guggenheim Partners, in the Healthcare group within the Investment Banking division. While at Guggenheim, Mr. Wang worked on a number of M&A transactions in the biopharmaceuticals vertical, including Pfizer’s proposed cross-border combination with Allergan and Pfizer’s acquisition of Medivation and Anacor.
Mr. Wang received a B.S. from Cornell University with a double major in Biological Sciences and Applied Economics and Management.